Revelation Biosciences, Inc. (REVB) NASDAQ

1.00

+0.0467(+4.90%)

Updated at December 04 04:00PM

Currency In USD

Valuation

Market Cap3.8M
Enterprise Value-2.7M
P/E Ratio-0.24
PEG Ratio-0.01
Price/Sales Ratio219.71
Price/Book Ratio0.24
Enterprise/Revenue-251.61
Enterprise/EBITDA0.82

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-404.18
Operating Margin-306.08

Management Effectiveness

Return On Assets-0.85
Return On Equity-1.94

Income Statement

Revenue0
Revenue/Share0.01
Gross Profit0
EBITDA-7.95M
Net Income-15.04M
Diluted EPS-87.68

Balance Sheet

Total Cash12.71M
Total Cash/Share4.81
Total Debt0
Total Debt/Equity0
Current Ratio6.92
Book Value Per Share4.16

Price History

52-Week Change-95.57
52-Week High60.48
52-Week Low0.83
Moving Average 50 Days1.18
Moving Average 200 Days4.52

Statistics

Average Volume412,226
Shares Outstanding5.92M
% Held by Institutions0.3

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.55
Last Split Factor1:3
Last Split DateJuly 07, 2025